Clinical Trial Update: Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression [NA]

View source ↗

Summary

The clinical trial of an inhibitor masking device targeting SCN9 gene expression for tinnitus was terminated, with results posted in January 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinnitus

Drugs mentioned

• Inhibitor Masking Device

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Tinnitus | NA | Status: TERMINATED | Results posted: 2016-01-18